检索结果-南通市图书馆

Chinese Medical Journal 2024年第9期137卷 1016-1018页

作者： The Society of cancer Precision Medicine of Chinese anti-cancer a.socia.ion The Lung cancer Expert Group of Chinese Medical a.socia.ion Publishing House Baohui Han Hua Zhong 不详 Department of Respiratory Medicine Shanghai Chest HospitalSchool of MedicineShanghai JiaoTong UniversityShanghai 20030China Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine

Non-small cell lung cancer(NSCLC)with oncogenic driver mutations was previously deemed“forbidden territory”for immunotherapy.[1]With the continuous generation of evidence,immunotherapy is expected to bring hope for such NSCLC with oncogenic driver mutations after acquired tyrosine kinase inhibitor(TKI)***,given the intricate interplay between driven mutations,targeted therapy,and immune microenvironment,the efcacy of immunotherapy in advanced NSCLC patients with diverse oncogenic driver mutations remains a topic of ongoing *** this context,Chinese Expert Consensus on Immunotherapy for Advanced NSCLC with Oncogenic Driver Mutations(2022 edition)wasrst launched in 2022 by the Society of cancer Precision Medicine of Chinese anti-cancer a.socia.ion and the Lung cancer Expert Group of Chinese Medical Journals,aiming to provide standardized treatment guidance for clinical practice.

关键词： immunotherapy cancer lung

在线全文

学校读者我要写书评

暂无评论

中西医整合乳腺癌长期用药专家共识

中华肿瘤防治杂志 2024年第13期31卷 785-799页

作者：朱世杰陈武进中国抗癌协会中西医整合乳腺癌专业委员会中国中医科学院望京医院福建中医药大学附属人民医院

随着乳腺癌患者总生存期(OS)的延长，乳腺癌长期用药问题引起了广泛的关注。然而，目前尚未有相关指南和共识针对乳腺癌患者中西医整合长期用药问题进行较为全面的指导和规范。中国抗癌协会中西医整合乳腺癌专业委员会专门针对乳腺癌中... 详细信息

随着乳腺癌患者总生存期(OS)的延长，乳腺癌长期用药问题引起了广泛的关注。然而，目前尚未有相关指南和共识针对乳腺癌患者中西医整合长期用药问题进行较为全面的指导和规范。中国抗癌协会中西医整合乳腺癌专业委员会专门针对乳腺癌中西医整合长期用药问题召开了3次研讨会，并最终制定了本共识。旨在进一步提高乳腺癌患者长期用药依从性，使患者能够达到有效的药物使用时长，并提高患者生活质量、延长OS。

关键词：乳腺肿瘤长期用药整合医学中西医整合专家共识

Cardiovascular Risk Factors in china

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第2期21卷 153-199页

作者： Sheng-Shou HU the Writing Committee of the Report on Cardiovascular Health and Diseases in china Fuwai Hospital National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina 不详

The Annual Report on Cardiovascular Health and Diseases in china(2022) intricate landscape of cardiovascular health in china. This section dissects cardiovascular risk factors in china which including hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease, metabolic syndrome and air pollution. Hypertension prevalence has steadily increased in china,with efforts to control it facing challenges in achieving optimal rates, especially in rural areas. Interventions like salt substitutes and intensive blood pressure control show promise but need improvement. Abnormal lipid levels, indicative of dyslipidemia,have risen significantly, posing a risk for cardiovascular diseases. Despite efforts, many patients struggle to achieve target lipid levels, necessitating improved treatment strategies. Both type 1 and type 2 diabetes mellitus affect millions of adults in china,with long-term complications adding to the disease burden. Early intervention and effective management are crucial to mitigate its impact. Prevalent among older adults, chronic kidney disease is associated with diabetes mellitus, hypertension, and cardiovascular diseases, necessitating comprehensive management approaches. The prevalence of metabolic syndrome, characterized by a cluster of risk factors, has increased in both adults and adolescents, calling for lifestyle modifications and public health interventions. Ambient and household air pollution remain significant environmental risk factors, despite some improvements in air quality. Continued efforts to reduce emissions are essential for mitigating associated health risks. Addressing these risk factors requires a multifaceted approach, including public health initiatives, policy interventions, and individual-level strategies to promote healthy lifestyles and reduce environmental exposures. Surveillance and research efforts are crucial for monitoring trends and developing effective strategies to lessen the burden of cardiovascular diseases in

关键词： landscape adding spite

Heart failure in china:epidemiology and current management

在线全文

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第6期21卷 631-641页

The Annual Report on Cardiovascular Health and Diseases in china(2022)intricate landscape of cardiovascularhealth in *** connection with the previous section,this sixth section of the report offers a comprehensive analysis of heart failure(HF)in *** is one of the most important cardiovascular disease in the 21st *** mortality is equivalent to that of *** is an important public health problem that seriously affects the health of Chinese *** recent years,with the deepeningof understanding,the change of treatment principles,the innovation of treatment methods and the update of treatment guidelines,the in-hospital mortality of HF patients has declined,and the long-term prognosis is also ***,there are stilldifferences in the management level of HF among different hospitals in *** to improve the standardized diagnosis andtreatment level of HF in china remains an important challenge.

关键词： epidemiology diagnosis treatment

Berry-Esseen bounds and moderate deviations for the norm, entries and spectral radius of products of positive random matrices

在线全文

学校读者我要写书评

暂无评论

Science china Mathematics 2024年第3期67卷 627-646页

作者： Hui Xiao ion Grama Quansheng Liu Institut fur Mathematik und Angewandte Informatik Universitat HildesheimHildesheim 31141Germany Academy of Mathematics and Systems Science Chinese Academy of SciencesBeijing 100190China LMBA Universite Bretagne SudCNRS UMR 6205Vannes F-56000France

Let(g_(n))_(n≥1) be a sequence of independent and identically distributed positive random d×d matrices and consider the matrix product G_(n)=g_(n)…g_*** suitable conditions,we establish the Berry-Esseen bounds on the rate of convergence in the central limit theorem and Cramer-type moderate deviation expansions,for any matrix norm ‖G_(n)‖ of G_(n),its entries G_(n)^(i,j) and its spectral radius ρ(G_(n)).Extended versions of their joint law with the direction of the random walk G_(n)x are also established,where x is a starting point in the unit sphere of R~d.

关键词： Berry-Esseen bound Cramér-type moderate deviation product of random matrices operator norm entry spectral radius

Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer(2024 edition)

在线全文

学校读者我要写书评

暂无评论

Radiation Medicine and Protection 2024年第2期5卷 59-67页

作者： Professional Committee of Radiation Oncology china anti-cancer a.socia.ion Branch of Radiation Oncology Chinese Medical a.socia.ion Branch of Radiation Oncology TreatmentPhysician Chinese Medical Doctor a.socia.ion Qingsong Pang Jun Wang Zhouguang Hui Wencheng Zhang 不详 Tianjin Medical University cancer Institute&Hospital Tianjin 300060China the Fourth Hospital of Hebei Medical University Shijiazhuang 050011China National cancer Center National Clinical Research Center for CancerCancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Tianjin Medical University cancer Hospital China

Radiotherapy represents an essential treatment approach for esophageal *** recent years,immunotherapy combined with chemotherapy has become the first-line standard treatment for patients with advanced esophageal *** phase III studies on immunotherapy combined with radiotherapy for locally advanced esophageal cancer are currently *** evidence-based medical data are urgently needed to support the integration of immunotherapy and chemoradiotherapy as a new treatment strategy for patients with locally advanced esophageal *** consensus,formulated based on the latest study results,in-depth research,and thorough discussions,provides a comprehensive set of *** document extensively covers treatment strategies and evaluation methods for radiotherapy combined with immunotherapy across patients with operable esophageal cancer,inoperable locally advanced esophageal cancer,and advanced esophageal ***,common complications and radiation-related issues associated with radiotherapy combined with immunotherapy are discussed,serving as clinical *** expert group comprised members from the Professional Committee of Radiation Oncology,china anti-cancer a.socia.ion,the Branch of Radiation Oncology,Chinese Medical a.socia.ion,and the Branch of Radiation Oncology Treatment Physician,Chinese Medical Doctor a.socia.ion.

关键词： Esophageal squamous cell carcinoma Esophageal adenocarcinoma Immunotherapy Chemoradiotherapy Radiotherapy Expert consensus

Pulmonary embolism and deep venous thrombosis in china

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第8期21卷 775-778页

The Annual Report on Cardiovascular Health and Diseases in china(2022) intricate landscape of cardiovascular health in *** connection with the previous section,this eighth section of the report offers a comprehensive analysis of pulmonary embolism and deep venous *** recent years,research in the field of pulmonary vessel in china has made great progress.A number of nationwide multi-center registry research results have filled the gaps in the epidemiology,diagnosis and treatment of pulmonary hypertension and venous *** types of pulmonary hypertension still need attention to the identification of risk factors and/or risk stratification,and venous thromboembolism needs attention in the prevention and the overall management inside and outside *** the future,we look forward to the publication of more high-quality research in china,which could be able to improve relevant guidelines for pulmonary vascular diseases both domestically and inter-nationally.

关键词： epidemiology prevention diagnosis

子宫颈癌免疫检查点抑制剂临床应用指南(2024年版)

在线全文

学校读者我要写书评

暂无评论

中国实用妇科与产科杂志 2024年第7期40卷 712-719页

作者：中国抗癌协会宫颈癌专业委员会周琦龙行涛不详重庆大学附属肿瘤医院妇科肿瘤中心、重庆市卵巢癌专病医学研究中心重庆40003 重庆大学附属肿瘤医院妇科肿瘤中心、重庆市卵巢癌专病医学研究中心重庆400030

子宫颈癌是全球女性第四大常见恶性肿瘤,2020年全球约有60.4万例新确诊病例,34.2万例死亡病例[1]。我国癌症中心发布的全国癌症统计数据报告显示,2022年中国子宫颈癌新发病例估计为15.07万例,死亡例数估计为5.57万例。农村的发病率和死... 详细信息

子宫颈癌是全球女性第四大常见恶性肿瘤,2020年全球约有60.4万例新确诊病例,34.2万例死亡病例[1]。我国癌症中心发布的全国癌症统计数据报告显示,2022年中国子宫颈癌新发病例估计为15.07万例,死亡例数估计为5.57万例。农村的发病率和死亡率均高于城市,且子宫颈癌发病有年轻化趋势[2]。晚期子宫颈癌治愈率低,亟待提高疗效。程序性死亡受体1(programmed death-1,PD-1)及程序性死亡受体配体1(programmed death ligand-1,PD-L1)抑制剂在晚期、复发子宫颈癌中显示了满意疗效。免疫检查点抑制剂(immune checkpoint inhibitors,ICI)通过阻断免疫检查点信号传递解除免疫抑制,恢复T细胞功能,从而有效激活免疫系统并产生抗肿瘤免疫应答杀伤肿瘤细胞。

关键词：子宫颈癌免疫检查点抑制剂指南

基于PD-L1蛋白表达水平的胃癌免疫治疗专家共识(2023年版)

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中国肿瘤临床 2024年第2期51卷 55-63页

作者：中国抗癌协会胃癌专业委员会梁寒朱正纲张艳桥不详

以程序性死亡蛋白-1(programmed death protein-1,PD-1)抑制剂为代表的免疫检查点抑制剂在胃癌中显示良好疗效,逐步改变晚期胃癌的治疗格局。对于程序性死亡蛋白配体-1(programmed death-ligand 1,PD-L1)高表达的患者,PD-L1单抗的治疗... 详细信息

以程序性死亡蛋白-1(programmed death protein-1,PD-1)抑制剂为代表的免疫检查点抑制剂在胃癌中显示良好疗效,逐步改变晚期胃癌的治疗格局。对于程序性死亡蛋白配体-1(programmed death-ligand 1,PD-L1)高表达的患者,PD-L1单抗的治疗效果更为优异,且与PD-L1蛋白表达水平呈正相关。而对于PD-L1阴性或低表达这类免疫治疗非优势人群,以PD-1单抗为基础的用药方案疗效有限,尝试双特异性抗体、ADC等不同药物的联合也是一种趋势。为了精准指导临床实践,中国抗癌协会胃癌专业委员会组织国内胃癌领域专家进行多轮讨论,系统汇总国内外最新指南和循证证据,并结合我国临床实际,从病理检测、晚期治疗以及围术期治疗3个方面制订了本专家共识,旨在提高胃癌诊治的科学性和规范性,尤其是指导基层医生对免疫治疗的选择和应用。

关键词：胃癌程序性死亡蛋白配体-1 免疫治疗专家共识

妇科肿瘤腹腔热灌注治疗临床药物应用专家共识(2024年版)

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中国实用妇科与产科杂志 2024年第1期40卷 62-67页

作者：中国抗癌协会宫颈癌专业委员会李晶林仲秋不详中山大学孙逸仙纪念医院妇科肿瘤专科广东广州510120

1背景妇科肿瘤有发生腹膜播散的倾向,特别是卵巢癌、子宫内膜癌和特殊类型子宫颈癌(包括子宫颈胃型腺癌和子宫颈黏液性腺癌)[1]。妇科肿瘤发生腹膜播散时,肿瘤细胞减灭术联合化疗是最常用的治疗手段,彻底切除肿瘤并及时进行静脉化疗是... 详细信息

1背景妇科肿瘤有发生腹膜播散的倾向,特别是卵巢癌、子宫内膜癌和特殊类型子宫颈癌(包括子宫颈胃型腺癌和子宫颈黏液性腺癌)[1]。妇科肿瘤发生腹膜播散时,肿瘤细胞减灭术联合化疗是最常用的治疗手段,彻底切除肿瘤并及时进行静脉化疗是改善腹膜播散性妇科肿瘤患者预后的重要方法。

关键词：妇科肿瘤腹腔热灌注治疗专家共识